PATENT CLAIM ANALYSIS

Application Number: 15981642
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "009600"]

Abstract:
Compositions and methods are provided for the generation or treatment of chronic tympanic membrane perforation by modulation of HB-EGF activity.

Claim (Index 1):
A method to promote closing of a chronic tympanic membrane perforation in an individual,\n wherein the method comprises contacting a site of chronic tympanic membrane perforation with a formulation comprising an effective dose of a soluble mature form of human heparin binding epidermal growth factor (HB-EGF) protein.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.05
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14583708', '14131710', '14745160', '10237144', '11947952']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.709335554962615
- 35 USC 102 Novelty (BERT): 0.4968968162538724
- Combined Prediction Score: 0.6880916810917408
- Mean Citation Score: 181.872208
- Max Citation Score: 208.9095
- Similarity Product: 138.20670404380562

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test